Effect of mangiferin isolated from Salacia chinensis regulates the kidney carbohydrate metabolism in streptozotocin-induced diabetic rats

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 3 SUPPL., 2012, Pages

  Sellamuthu, Periyar Selvam ^a   Arulselvan, Palanisamy ^b   Muniappan, Balu Periamallipatti ^a   Kandasamy, Murugesan ^a  

^a UNIVERSITY OF MADRAS   (India)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

Carbohydrate metabolism; Diabetes; Mangiferin; Streptozotocin

Indexed keywords

FRUCTOSE BISPHOSPHATASE; GLIBENCLAMIDE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEXOKINASE; LACTATE DEHYDROGENASE; MANGIFERIN; PYRUVATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; MALE; METABOLIC REGULATION; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; RAT; SALACIA; SALACIA CHINENSIS; STREPTOZOCIN DIABETES;

RATTUS; SALACIA CHINENSIS;

EID: 84875406129     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60457-2     Document Type: Article

References (40)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
2. Lin Y, Sun Z Current views on type 2 diabetes. J Endocrinol 2010, 204:1-11.
3. Whiting DR, Guariguata L, Weil C, Shaw J IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
4. IDF. Diabetes Atlas 4th Edition, International Diabetes Federation. President of International Diabetes Federation calls for concerted action to stop diabetes epidemic. Montreal Canada. 2009.
5. Klarenbach S, Cameron C, Singh S, Ur E Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin. CMAJ 2011, 183:E1213-E1220.
6. Blonde L Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. Am J Med 2010, 123:S12-S18.
7. Etxeberria U, de la Garza AL, Campión J, Martínez JA, Milagro FI, Matthew KM Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opin Ther Targets 2012, 16:269-297.
8. Matthew KM. The Flora of the Tamilnadu Carnatic: 1981; 265.
9. Deokate UA, Khadabadi SS Phytopharmacological aspects of Salacia chinensis. J Pharmacognosy Phytother 2012, 4:1-5.
10. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 2010, 10:729-745.
11. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 2005, 97:497-501.
12. Petrova A, Davids LM, Rautenbach F, Marnewick JL Photoprotection by honeybush extracts, hesperidin and mangiferin against UVB-induced skin damage in SKH-1 mice. J Photochem Photobiol B 2011, 103:126-139.
13. Garrido G, Delgado R, Lemus Y, Rodríguez J, García D, Núñez-Sellés AJ Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANG). Role of mangiferin isolated from the extract. Pharmacol Res 2004, 50:165-172.
14. Ghosh M, Das J, Sil PC D (+) galactosamine induced oxidative and nitrosative stress-mediated renal damage in rats via NF-κB and inducible nitric oxide synthase (iNOS) pathways is ameliorated by a polyphenol xanthone, mangiferin. Free Radic Res 2012, 46:116-132.
15. Pardo-Andreu GL, Barrios MF, Curti C, Hernández I, Merino N, Lemus Y, Martínez I, Riaño A, Delgado R Protective effects of Mangifera indica L extract (Vimang), and its major component mangiferin, on iron-induced oxidative damage to rat serum and liver. Pharmacol Res 2008, 57:79-86.
16. Periyar Selvam S, Balu PM, Sathiya moorthi P, Murugesan K Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 2009, 55:206-214.
17. Arulselvan P, Subramanian S Ultrastructural and biochemical abnormalities in the liver of streptozotocin-diabetic rats: Protective effects of Murraya koenigii. J Pharmacol Toxicol 2008, 3:190-202.
18. Sasaki T, Matsy S, Somae A Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsoho Kagaku 1972, 1:346-353.
19. Brandstrup N, Kirk JE, Bruni C The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1957, 12:166-171.
20. King J Colorimetric determination of serum lactate dehydrogenase. J Med Lab Tech 1959, 16:265-269.
21. Koide H, Oda T Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin Chim Acta 1959, 4:554-561.
22. Pogson CI, Denton RM Effect of alloxan diabetes, starvation and refeeding on glycolytic kinase activities in rat epididymal adipose tissue. Nature 1967, 216:156-157.
23. Gancedo JM, Gancedo C Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeasts. Arch Mikrobiol 1971, 76:132-138.
24. Ells HA, Kirkman HN A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1961, 106:607-609.
25. Singh SK, Rai PK, Jaiswal D, Watal G Evidence-based Critical Evaluation of Glycemic Potential of Cynodon dactylon. Evid Based Complement Alternat Med 2008, 5:415-420.
26. Latorre R, Hernández W, Sun F, Sánchez-Margallo F, Gil F, López-Albors O, Vázquez JM, Usón J Evaluation of wedged arterial injection as a new technique for delivery of experimental therapeutic substances into the porcine pancreas. Exp Diabetes Res 2011, 976910.
27. Rakieten N, Rakieten ML, Nadkarni MV Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963, 29:91-98.
28. Berthold HK, Bestehorn KP, Jannowitz C, Krone W, Gouni-Berthold I Disease management programs in type 2 diabetes: quality of care. Am J Manag Care 2011, 17:393-403.
29. Fonseca VA, Kirkman MS, Darsow T, Ratner RE The American diabetes association diabetes research perspective. Diabetes Care 2012, 35:1380-1387.
30. Adeyi AO, Idowu BA, Mafiana CF, Oluwalana SA, Ajayi OL, Akinloye OA Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathology. Int J Physiol Pathophysiol Pharmacol 2012, 4:51-58.
31. Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2012, 156:218-231.
32. Arulselvan P, Subramanian S Effect of Murraya koenigii leaf extract on carbohydrate metabolism studied in streptozotocin induced diabetic rats. Int J Biol Chem 2007, 1:21-28.
33. Sunil C, Agastian P, Kumarappan C, Ignacimuthu S In vitro antioxidant, antidiabetic and antilipidemic activities of Symplocos cochinchinensis (Lour.) S. Moore bark. Food Chem Toxicol 2012, 50:1547-1553.
34. Dieni CA, Storey KB Regulation of hexokinase by reversible phosphorylation in skeletal muscle of a freeze-tolerant frog. Comp Biochem Physiol B Biochem Mol Biol 2011, 159:236-243.
35. Fridlyand LE, Philipson LH Glucose sensing in the pancreatic beta cell: a computational systems analysis. Theor Biol Med Model 2010, 7:15.
36. Mitrakou A Kidney: its impact on glucose homeostasis and hormonal regulation. Diabetes Res Clin Pract 2011, 93:S66-S72.
37. Du J, Say RF, Lü W, Fuchs G, Einsle O Active-site remodelling in the bifunctional fructose-1,6-bisphosphate aldolase/phosphatase. Nature 2011, 478:534-537.
38. Kebede M, Favaloro J, Gunton JE, Laybutt DR, Shaw M, Wong N, Fam BC, Aston-Mourney K, Rantzau C, Zulli A, Proietto J, Andrikopoulos S Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 2008, 57:1887-1895.
39. Pessôa BS, Peixoto EB, Papadimitriou A, Lopes de Faria JM, Lopes de Faria JB Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin Angiotensin Aldosterone Syst 2012, 13:56-66.
40. Zhang Zhaoyun, Liew Chong Wee, Handy Diane E., Zhang Yingyi, Leopold Jane A., Hu Ji, Guo Lili, Kulkarni Rohit N., Loscalzo Joseph, Stanton Robert C. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and β-cell apoptosis. FASEB J 2010, 24:1497-1505.